Patient Preferences Regarding Surgical Treatment Methods for Symptomatic Uterine Fibroids

Olufemi Babalola1, David Gebben2, Michelle E Tarver2

  • 1Patient Science & Engagement, Office of Strategic Partnerships and Technology Innovation, Center for Devices and Radiological Health, U.S. Food and Drug Administration, White Oak, Bldg. 66, Room 5574, Silver Spring, MD, 20993, USA. Olufemi.babalola@fda.hhs.gov.

Abstract